Table 2.
Multivariate models examining prescriber factors and relationship with practices for assessing and mitigating diversion (N=1,174)
| Assesses all patients for diversion (logistic regression) AOR (95% CI) |
Frequency of office visits in early treatment (ordinal regression) AOR (95% CI) |
Always tests urine screen for buprenorphine (logistic regression) AOR (95% CI) |
Percentage of patients with medication counts (negative binomial regression) IRR (95% CI) |
|
|---|---|---|---|---|
| Magnitude of the diversion problem in the community | 1.188** (1.060, 1.332) |
1.202** (1.060, 1.361) |
1.278* (1.055, 1.550) |
1.186*** (1.081, 1.302) |
| Buprenorphine practice characteristics | ||||
| Delivers buprenorphine treatment in individual medical practice (vs. no individual practice) | 0.996 (0.759, 1.308) |
0.806 (−0.628, 1.034) |
0.953 (0.640, 1.418) |
0.887 (0.756, 1.041) |
| Payment typology | ||||
| Only accepts cash | Reference | Reference | Reference | Reference |
| Accepts private insurance but not Medicaid | 1.019 (0.729, 1.423) |
1.348 (0.963, 1.888) |
0.812 (0.450, 1.464) |
1.139 (0.934, 1.388) |
| Accepts Medicaid | 1.148 (0.776, 1.697) |
1.814** (1.213, 2.711) |
0.955 (0.612, 1.489) |
0.992 (0.791, 1.244) |
| All other types of payment | 0.879 (0.367, 2.104) |
1.684*+ (1.009, 2.811) |
1.328 (0.448, 3.937) |
0.920 (0.556, 1.523) |
| Current number of buprenorphine patients | 1.001 (0.998, 1.004) |
0.996 (0.993, 1.000) |
1.017*** (1.010, 1.024) |
1.003*+ (1.000, 1.011) |
| Years of prescribing buprenorphine | 0.942** (0.909, 0.976) |
0.992 (0.962, 1.024) |
0.894*** (0.861, 0.929) |
0.994 (0.977, 1.011) |
| Waivered to treat up to 100 patients (vs. 30 patients) | 1.080 (0.742, 1.572) |
0.839 (0.632, 1.114) |
1.641** (1.159, 2.322) |
0.917 (0.754, 1.115) |
| Prescriber characteristics | ||||
| Medical specialty | ||||
| Addiction (psychiatry or medicine) | 1.063 (0.701, 1.611) |
1.762** (1.245, 2.493) |
1.077 (0.674, 1.721) |
0.816 (0.665, 1.003) |
| Psychiatry | 0.969 (0.711, 1.322) |
1.817*** (1.366, 2.418) |
0.551*** (0.404, 0.753) |
0.901 (0.732, 1.110) |
| All other specialties | Reference | Reference | Reference | Reference |
| Member of ASAM/AAAP (vs member of neither) | 1.044 (0.713, 1.529) |
1.556*+ (1.042, 2.322) |
1.012 (0.680, 1.506) |
1.358*** (1.173, 1.573) |
| Age | 0.991 (0.977, 1.006) |
1.000 (0.991, 1.009) |
0.992 (0.975, 1.009) |
1.003 (0.996, 1.011) |
| Female (vs. male) | 1.081 (0.761, 1.535) |
1.267 (0.949, 1.692) |
1.270 (0.832, 1.941) |
0.937 (0.772, 1.138) |
| Non-white (vs. white) | 0.541*** (0.401, 0.730) |
0.890 (0.693, 1.141) |
0.714*+ (0.510, 0.999) |
1.209 (0.953, 1.535) |
| Constant | 7.248*** (3.085, 17.0 32) |
n/a | 4.955** (1.793, 13.690) |
18.495 (10.052, 34.030) |
| Threshold 1 | n/a | 0.171 (−0.578, 0.919) |
n/a | n/a |
| Threshold 2 | n/a | 1.788 (1.105, 2.561) |
n/a | n/a |
Notes.
p<.05,
p<.01,
p<.001 (two-tailed tests).
p-value exceeds the false discovery rate (FDR) value for statistical significance when adjusting for multiple comparisons.
AOR = adjusted odds ratio. IRR = incidence rate ratio. CI = confidence interval. Pooled estimates were calculated from models estimated using 20 imputed datasets (n = 1,174). All models used robust standard errors to adjust for the clustering of prescribers within states. For the model of frequency of office visits, the thresholds represent estimated cutpoints on the underlying latent variable of office visits. Threshold 1 is the estimated cutpoint used to differentiate “monthly visits or less” responses from the other two categories when values of the independent variables are zero. Threshold 2 is the estimated cutpoint that differentiates the groups “monthly visits or less” and “every two weeks” from the “weekly or more” group when the independent variables are set at zero.